Related Experiment Video

Updated: Dec 14, 2025

Fertility Preservation Through Oocyte Vitrification: Clinical and Laboratory Perspectives

Fertility Preservation Through Oocyte Vitrification: Clinical and Laboratory Perspectives

Published on: September 16, 2021

Ovarian hyperstimulation syndrome after assisted reproductive technologies: trends, predictors, and pregnancy

David A Schirmer¹, Aniket D Kulkarni², Yujia Zhang²

¹Division of Reproductive Health, National Center for Chronic Disease Prevention and Health Promotion, Centers for Disease Control and Prevention, Atlanta, Georgia; Department of Gynecology and Obstetrics, School of Medicine, Emory University, Atlanta, Georgia.

Fertility and Sterility

|July 19, 2020

Abstract

Objectives:

To assess trends, predictors, and perinatal outcomes of ovarian hyperstimulation syndrome (OHSS) associated with in vitro fertilization (IVF) cycles in the United States.

Design:

Retrospective cohort study using National Assisted Reproductive Technology Surveillance System (NASS) data.

Setting:

Not applicable.

Patient(S):

Fresh autologous and embryo-banking cycles performed from 2000 to 2015.

Interventions(S):

None.

Main Outcome Measure(S):

OHSS, first-trimester loss, second-trimester loss, stillbirth, low birth weight, and preterm delivery.

Result(S):

The proportion of IVF cycles complicated by OHSS increased from 10.0 to 14.3 cases per 1,000 from 2000 to 2006, and decreased to 5.3 per 1,000 from 2006 to 2015. The risk of OHSS was highest for cycles with more than 30 oocytes retrieved (adjusted risk ratio [aRR] 3.85). OHSS was associated with a diagnosis of ovulatory disorder (aRR 2.61), tubal factor (aRR 1.14), uterine factor (aRR 1.17) and cycles resulting in pregnancy (aRR 3.12). In singleton pregnancies, OHSS was associated with increased risk of low birth weight (aRR 1.29) and preterm delivery (aRR 1.32). In twin pregnancies, OHSS was associated with an increased risk of second-trimester loss (aRR 1.81), low birth weight (aRR 1.06), and preterm delivery (aRR 1.16).

Conclusion(S):

Modifiable predictive factors for OHSS include number of oocytes retrieved, pregnancy following fresh embryo transfer, and the type of medication used for pituitary suppression during controlled ovarian hyperstimulation. Patients affected by OHSS had a higher risk of preterm delivery and low birth weight. Clinicians should take measures to reduce the risk of OHSS whenever possible.

Keywords:

IVF OHSS Ovarian hyperstimulation syndrome safety of ART

More Related Videos

Fertility Preservation in Patients with Severe Ovarian Dysfunction

Fertility Preservation in Patients with Severe Ovarian Dysfunction

Published on: March 25, 2021

OP-IVM: Combining In vitro Maturation after Oocyte Retrieval with Gynecological Surgery

OP-IVM: Combining In vitro Maturation after Oocyte Retrieval with Gynecological Surgery

Published on: May 9, 2021

Related Concept Videos

Oogenesis

Oogenesis

In human women, oogenesis produces one mature egg cell or ovum for every precursor cell that enters meiosis. This process differs in two unique ways from the equivalent procedure of spermatogenesis in males. First, meiotic divisions during oogenesis are asymmetric, meaning that a large oocyte (containing most of the cytoplasm) and minor polar body are produced as a result of meiosis I, and again following meiosis II. Since only oocytes will go on to form embryos if fertilized, this unequal...

In Vitro Fertilization

In Vitro Fertilization

In vitro fertilization (IVF) is a form of assisted reproductive technology where an egg is fertilized with sperm in a controlled laboratory environment before transferring the resulting embryo into the uterus. This process is designed to help individuals and couples experiencing difficulties conceiving.
The IVF process begins with ovarian stimulation, during which reproductive endocrinologists prescribe hormonal medications to stimulate the ovaries to produce multiple eggs instead of the single...

Ovarian Cycle

Ovarian Cycle

The menstrual cycle includes a critical component known as the ovarian cycle, which undergoes two main phases each month—the follicular phase and the luteal phase. The follicular phase is variable and averaging around 14 days. Ovulation, triggered by a surge in luteinizing hormone (LH), marks the transition between the two phases. The second phase, the luteal phase, is relatively consistent, lasting approximately 14 days, and is marked by the activity of the corpus luteum. While a cycle...

Infertility in Females

Infertility in Females

Female infertility is defined as the inability to conceive after a year of regular, unprotected intercourse and affects about 10–15% of couples worldwide. The primary cause of female infertility is ovulatory disorders, which hinder the release of eggs. These disorders can be classified as hypothalamic amenorrhea, polycystic ovarian syndrome (PCOS), premature ovarian failure, and hyperprolactinemic anovulation disorders.
Endometriosis, a condition characterized by abnormal growth of...

Articles linked to this work by shared authors, journal, and citation graph.

Effect of a patient-centered planning intervention on postpartum visit attendance.

Pregnancy (Hoboken, N.J.)·2026

A Community-Based Participatory Approach to Develop a Social Risk Screening Protocol, Tailored to the Needs of Pregnant and Postpartum People in Metro Atlanta.

Health equity·2026

Unmasking obstetric care providers' empathy and color evasion in maternal health disparities: a causal attribution, mixed-methods study with an ideal-type analysis.

BMC public health·2026

Infertility Prevalence and Public Support for In Vitro Fertilization Policies in the United States.

Journal of women's health (2002)·2026

What happens at the postpartum visit? Discordance between patient-reported and electronic medical record-documented postpartum care.

Annals of epidemiology·2026

Physician Management of Non-Cavity Distorting Intramural Fibroids and Infertility: A Survey of REI Providers.

International journal of women's health·2026

See all related articles